The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, melanoma, and gastric cancer, and plays a pivotal role in the process of oncogenesi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Hematol Oncol
Hlavní autoři: Shi, Cunzhen, Li, Xiangqun, Wang, Xiaogan, Ding, Ning, Ping, Lingyan, Shi, Yunfei, Mi, Lan, Lai, Yumei, Song, Yuqin, Zhu, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859520/
https://ncbi.nlm.nih.gov/pubmed/29554921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0584-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky